Skip to content
Search

Latest Stories

DHSC publishes proposals to amend pharmacy governance, current legislation on dispensing errors

The Department of Health and Social Care (DHSC) has published plans to amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.

The Department's response to a public consultation on rebalancing medicines legislation and pharmacy regulation programme first proposed in summer 2018 was delayed due to Brexit and the Covid-19 pandemic.


The programme aims to clarify and strengthen the organizational governance arrangements of registered pharmacies, specifically to define and clarify the core purpose of the Responsible Pharmacist and Superintendent Pharmacist roles.

It will also give the General Pharmaceutical Council (GPhC) powers to define in professional standards how those roles are fulfilled.

These plans are part of a wider commitment from the government to pursue legislative change to make better use of the skill mix in pharmacy teams to deliver more clinical services in the community and support wider NHS capacity.

The orders will now progress through Parliament and, pending approval by both Houses, would need final approval by the Privy Council before they can commence.

More For You

Beware of wage theft: PDA warns locums

Booking terms should clearly outline not only the dates of work, shift times, and rate of pay but also the required notice period

Getty Images

PDA warns locum pharmacists of ‘wage theft’ risk

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to check booking terms carefully before accepting shifts, warning of the risk of ‘wage theft’ and delayed payments.

According to the union, locum members have reported being owed significant unpaid fees for services provided, with some pharmacists claiming debts exceeding £20,000."

Keep ReadingShow less
UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less